These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1734692)

  • 1. Aluminum and TPN-related bone disease.
    Klein GL; Alfrey AC; Shike M; Sherrard DJ
    Am J Clin Nutr; 1992 Feb; 55(2):483-5. PubMed ID: 1734692
    [No Abstract]   [Full Text] [Related]  

  • 2. Aluminum in parenteral products: analysis, reduction, and implications for pediatric TPN.
    Rabinow BE; Ericson S; Shelborne T
    J Parenter Sci Technol; 1989; 43(3):132-9. PubMed ID: 2499670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total parenteral nutrition and its effects on bone metabolism.
    Klein GL; Coburn JW
    Crit Rev Clin Lab Sci; 1994; 31(2):135-67. PubMed ID: 7917007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aluminum in parenteral products: medical perspective on large and small volume parenterals.
    Klein GL
    J Parenter Sci Technol; 1989; 43(3):120-4. PubMed ID: 2499667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parenteral drug products containing aluminum as an ingredient or a contaminant: response to Food and Drug Administration notice of intent and request for information. ASCN/A.S.P.E.N. Working Group on Standards for Aluminum Content of Parenteral Nutrition Solutions.
    JPEN J Parenter Enteral Nutr; 1991; 15(2):194-8. PubMed ID: 1904955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Special report from ASCN/A.S.P.E.N. Working Group on Standards for Aluminum Content of Parenteral Nutrition Solutions.
    Koo WW; Chesney RW
    JPEN J Parenter Enteral Nutr; 1992; 16(1):92-5. PubMed ID: 1738229
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic bone disease of total parenteral nutrition.
    Klein GL
    Nutrition; 1998 Jan; 14(1):149-52. PubMed ID: 9437701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral aluminum loading in critical care medicine. Part II: Response to aluminum load from long-term parenteral nutrition.
    Gramm HJ; Brätter P; Rösick U; Kopf A; Bohge P; Recknagel S
    Infusionsther Transfusionsmed; 1994 Oct; 21(5):298-303. PubMed ID: 7803991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteomalacia and bone disease arising from aluminum.
    Coburn JW; Norris KC; Nebeker HG
    Semin Nephrol; 1986 Mar; 6(1):68-89. PubMed ID: 3110896
    [No Abstract]   [Full Text] [Related]  

  • 10. Polyethylene vials of calcium gluconate reduce aluminum contamination of TPN.
    Frey OR; Maier L
    Ann Pharmacother; 2000 Jun; 34(6):811-2. PubMed ID: 10860144
    [No Abstract]   [Full Text] [Related]  

  • 11. Aluminum in large and small volume parenterals used in total parenteral nutrition--FDA. Proposed rule.
    Fed Regist; 1998 Jan; 63(2):176-85. PubMed ID: 10176836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aluminum loading during total parenteral nutrition.
    Klein GL; Alfrey AC; Miller NL; Sherrard DJ; Hazlet TK; Ament ME; Coburn JW
    Am J Clin Nutr; 1982 Jun; 35(6):1425-9. PubMed ID: 6805302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocalcemia complicating deferoxamine therapy in an infant with parenteral nutrition-associated aluminum overload: evidence for a role of aluminum in the bone disease of infants.
    Klein GL; Snodgrass WR; Griffin MP; Miller NL; Alfrey AC
    J Pediatr Gastroenterol Nutr; 1989 Oct; 9(3):400-3. PubMed ID: 2515268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aluminum does not accumulate in teenagers and adults on prolonged parenteral nutrition containing free amino acids.
    Heyman MB; Klein GL; Wong A; Recker RR; Tyrrell JB; Alfrey AC; Sherrard DJ; Hohn DC
    JPEN J Parenter Enteral Nutr; 1986; 10(1):86-7. PubMed ID: 3080630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parenteral drug products containing aluminum as an ingredient or a contaminant: response to FDA notice of intent. ASCN/ASPEN Working Group on Standards for Aluminum Content of Parenteral Nutrition Solutions.
    Klein GL; Alfrey AC; Shike M; Sherrard DJ
    Am J Clin Nutr; 1991 Feb; 53(2):399-402. PubMed ID: 1899171
    [No Abstract]   [Full Text] [Related]  

  • 16. Aluminum as a factor in the bone disease of long-term parenteral nutrition.
    Klein GL; Ott SM; Alfrey AC; Sherrard DJ; Hazlet TK; Miller NL; Maloney NA; Berquist WE; Ament ME; Coburn JW
    Trans Assoc Am Physicians; 1982; 95():155-64. PubMed ID: 6820740
    [No Abstract]   [Full Text] [Related]  

  • 17. Aluminum in parenteral products: LVP and SVP, FDA medical perspective.
    Kenealy JC
    J Parenter Sci Technol; 1989; 43(3):125-6. PubMed ID: 2499668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic bone disease of total parenteral nutrition: course after changing from casein to amino acids in parenteral solutions with reduced aluminum content.
    Vargas JH; Klein GL; Ament ME; Ott SM; Sherrard DJ; Horst RL; Berquist WE; Alfrey AC; Slatopolsky E; Coburn JW
    Am J Clin Nutr; 1988 Oct; 48(4):1070-8. PubMed ID: 3138907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aluminum contamination of parenteral nutrition and aluminum loading in children on long-term parenteral nutrition.
    Advenier E; Landry C; Colomb V; Cognon C; Pradeau D; Florent M; Goulet O; Ricour C; Corriol O
    J Pediatr Gastroenterol Nutr; 2003 Apr; 36(4):448-53. PubMed ID: 12658033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aluminum in parenteral products: overview of chemistry concerns and regulatory actions.
    Hoiberg CP
    J Parenter Sci Technol; 1989; 43(3):127-31. PubMed ID: 2499669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.